iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Eli Lilly and Company brand value has increased by 36% in 2025 to $8 billion, making it the fastest-growing pharma brand and elevating it to the second most valuable in the industry GLP-1 Antagonists Increase Plan Drug

Enter THCV, a cannabinoid that takes a fundamentally different approach

Immune and hormonal activity in adults suffering from depression

Many PlexusDx patients report that this appetite suppression feels qualitatively different from willpower-based calorie restriction

Unlike single-pathway medications, Tirzepatides dual mechanism helps improve blood sugar control while also contributing to significant weight loss a major advantage for patients who are overweight or obese

Genetics: Some individuals may be genetically predisposed to oily or acne-prone skin

High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity